Logo

UgenTec Interpretation Solution for PathoFinder PCR 2SMART Assays

Apr 05, 2017

UgenTec and PathoFinder have launched a cloud-based CE-IVD interpretation solution for PathoFinder's next generation multiplex PCR 2SMART assays. The solution uses UgenTect software to automate the interpretation of pathogens detected in PathoFinder's syndromic infectious disease panels. The solution has been rolled out to more than ten laboratories across Europe and the Middle East.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.